Digital
People need to know how to use AI now
With the implementation of advancing technologies in industry comes …
19696 items found
News
Remembering Paul Bannister, dear friend and finance manager
On Sunday 28th July, pharmaphorum lost a much-beloved member of the …
News
Galderma gets FDA nod for prurigo nodularis therapy
Dermatology specialist Galderma has FDA approval for prurigo …
News
Digital health fund makes debut with $21m for start-ups
A group of healthcare industry veterans have launched a new …
News
Judge rebuffs Novartis bid to block generic Entresto
A judge in the US has denied an attempt by Novartis to stop MSN …
Digital
Sponsored
Advancing precision medicine: How real-world evidence platforms translate data into action
In the era of precision medicine, life sciences teams can utilise …
News
FDA okays Ascendis hypoparathyroidism drug at second attempt
After turning it down a year ago, the FDA has cleared once-daily …
News
Article retractions muddy MDMA waters after FDA denial
The journal Psychopharmacology has retracted three articles about …
Market Access
The politics of health: How elections will impact life sciences
The global landscape for medical technology, biotechnology, and life …
News
NICE updates on controversial multiple myeloma decisions
NICE has defended a trio of decisions on new therapies for multiple …
News
Another AIM defection as BiVictriX plans to delist
The list of UK biotechs deciding to abandon listings on the AIM …
News
FDA clears first anaphylaxis nasal spray at second attempt
ARS Pharma has claimed FDA approval for its epinephrine nasal spray …
News
PursueCare brings Pear addiction DTx apps back to life
Two pioneering digital therapeutics (DTx) for addiction are available once again after their original developer Pear Therapeutics was dissolved last year.
Digital
Sponsored
Decoding physician prescribing behaviour: A data-driven jour...
Identifying high-volume prescribers and engaging with key opinion leaders (KOLs) in a target therapeutic area can be a challenge.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
R&D
Partner Content
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
